<DOC>
	<DOCNO>NCT02384031</DOCNO>
	<brief_summary>Post-dural puncture headache ( PDPH ) common complication follow lumbar puncture ( LP ) . The frequency vary widely depending number factor , among patient characteristic , case ascertainment , gauge type needle use significant importance . In 2001 , Strupp et al . show 12 % 115 patient subject diagnostic lumbar puncture 22 gg ( 0.7 mm ) atraumatic needle suffer post-dural puncture headache , 24 % 115 give lumbar puncture 22 gg traumatic needle suffer headache . This finding provide basis American recommendation use 22 gg atraumatic needle diagnostic lumbar puncture . A late study 58 patient show even great difference ( 36 % versus 3 % post-dural puncture headache ) atraumatic needle use . Despite finding , European Neurologist continue hold cut needle . Here investigator propose prospective randomize study design double masking ; neither patient evaluator PDPH aware needle design use , active ascertainment occurrence PDPH accordance update headache classification guideline . The investigator also intend investigate whether specific neuroinflammatory substance metabolite ( different outcome variable ) cerebrospinal fluid ( CSF ) affect explanatory variable .</brief_summary>
	<brief_title>Post-dural Puncture Headache - Needles Biomarkers CSF</brief_title>
	<detailed_description>Subjects patient schedule diagnostic LP part routine clinical management department Neurology , Nordland Hospital Bodø , Norway . Selection base inclusion exclusion criterion list beneath , independent primary clinical indication procedure . Informed consent patient randomise two group base needle type . The traumatic group use Spinocan® ( Quincke ) 22Gx3.5 '' needle atraumatic group use Pencan® ( Sprotte ) 22Gx3.5 '' needle . The randomisation process via internet web-based application , provide Norwegian university science Technology ( http : //www.ntnu.edu/dmf/akf/randomisering ) . Subjects undergo standard lumbar puncture , lateral recumbent position , needle insert , preferentially level L3-4 , perpendicular parallel dural fiber , CSF collect accordance study protocol . Information LP , eventual complication , CSF volumes tapped standard CSF-findings note . Follow-up perform investigator mask randomization . Patients interview telephone , alternatively person hospitalise , first 1 7th day LP.Subjects develop PDPH treat in-line establish standardized protocol department Neurology , Nordland Hospital Trust , Bodø . Given PDPH natural history spontaneous resolution within 1-12 day , patient suffer PDPH treat conservatively duration first 7 day PDPH diagnosis . Conservative therapy , base symptom severity patient ' responsiveness , consist following : bed rest , caffeine , analgesic ( paracetamol , NSAIDS ) , antiemetic i.v . hydration . If headache severe disable non-respondent 7 day conservative therapy , epidural blood patch administer . If patient diagnose PDPH change pain character , develop additional neurological manifestation , urgent brain CT scan MRI indicate exclude rarer potentially life-threatening intracranial complication .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Post-Dural Puncture Headache</mesh_term>
	<criteria>1 . Patients Department Neurology , Nordland Hospital Trust Bodø , schedule diagnostic LP 1 . Dementia 2 . Noncompliance coma 3 . Local skin infection propose puncture site 4 . Suspicion raise intracranial pressure due neurological radiological finding 5 . Bleeding diathesis ( thrombocytopenia &lt; 50 x 109/L ) ongoing anticoagulant therapy 6 . Major spinal column deformity 7 . Procedural complication whereby needle type size change requisite 8 . Recent LP ( &lt; 7 day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>